Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -157.56% is 64% above its 5-year average of -440.28%, near the high end of its 5-year range (-762.19%–-85.82%).
49.08% above its 12-month average of -309.44%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -43.13%.
RETURN ON ASSETS (ROA)
-157.56%
RETURN ON ASSETS (ROA) AVG TTM
-309.44%
RETURN ON ASSETS (ROA) AVG 3Y
-441.71%
RETURN ON ASSETS (ROA) AVG 5Y
-440.28%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+49.08%
CURRENT VS 3Y AVG
+64.33%
CURRENT VS 5Y AVG
+64.21%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-388.71%
vs the sector median at left
SeaStar Medical Holding Corporation
Market Cap
$9.05M
Return on Assets (ROA)
-157.56%
TTM Avg
-309.44%
3Y Avg
-441.71%
5Y Avg
-440.28%
Market Cap
$9.10M
Return on Assets (ROA)
-269.20%
TTM Avg
-150.53%
3Y Avg
-111.73%
5Y Avg
-102.54%
Market Cap
$8.82M
Return on Assets (ROA)
-6.36%
TTM Avg
-31.97%
3Y Avg
-31.64%
5Y Avg
-61.82%
Market Cap
$9.50M
Return on Assets (ROA)
-73.89%
TTM Avg
-61.17%
3Y Avg
-50.83%
5Y Avg
-128.36%
Market Cap
$9.71M
Return on Assets (ROA)
-52.23%
TTM Avg
-58.24%
3Y Avg
-82.00%
5Y Avg
-104.09%
Market Cap
$9.72M
Return on Assets (ROA)
-149.72%
TTM Avg
-86.94%
3Y Avg
-66.39%
5Y Avg
-60.64%
Market Cap
$9.75M
Return on Assets (ROA)
-108.85%
TTM Avg
-94.23%
3Y Avg
-71.21%
5Y Avg
-107.74%
Market Cap
$8.33M
Return on Assets (ROA)
-23.11%
TTM Avg
-173.03%
3Y Avg
-145.25%
5Y Avg
-97.33%
Market Cap
$9.83M
Return on Assets (ROA)
-115.57%
TTM Avg
-131.41%
3Y Avg
-121.81%
5Y Avg
-149.86%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SeaStar Medical Holding Corporation (ICU) | $9.05M | -157.56% | -309.44% | -441.71% | -440.28% |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.10M | -269.20% | -150.53% | -111.73% | -102.54% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $8.82M | -6.36% | -31.97% | -31.64% | -61.82% |
| Ainos, Inc. (AIMD)vs › | $9.50M | -73.89% | -61.17% | -50.83% | -128.36% |
| Satellos Bioscience Inc. (MSLE)vs › | $9.71M | -52.23% | -58.24% | -82.00% | -104.09% |
| Senti Biosciences, Inc. (SNTI)vs › | $9.72M | -149.72% | -86.94% | -66.39% | -60.64% |
| MetaVia Inc. (MTVA)vs › | $9.75M | -108.85% | -94.23% | -71.21% | -107.74% |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.33M | -23.11% | -173.03% | -145.25% | -97.33% |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.83M | -115.57% | -131.41% | -121.81% | -149.86% |
| HeartSciences Inc. (HSCS)vs › | $8.14M | N/A | -103.86% | -117.64% | -138.14% |
ROA
-157.6%
ROE
-317.2%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -85.82% |
| 2024-12-31 | -533.06% |
| 2023-12-31 | -746.71% |
| 2022-12-31 | -401.25% |
| 2021-12-31 | -762.19% |
| 2020-12-31 | -112.62% |
